{
  "ptid_time": "022_S_4291_2014-02-12",
  "img_path": "/data/qiuhui/data/adni/images/022_S_4291/2014-02-12/t1.nii.gz",
  "img_finding": "Image findings: ventricular volume measures 68,147 mm³, 142.8% above the reference mean. With a Z-score of 3.27 (99.9th percentile), this represents profound enlargement; whole brain volume measures 913,725 mm³, 6.3% below the reference mean. With a Z-score of -0.79 (21.6th percentile), this represents normal volume ; entorhinal cortex volume measures 3,725 mm³, 1.4% above the reference mean. With a Z-score of 0.09 (53.5th percentile), this represents normal volume ; fusiform gyrus volume measures 16,992 mm³, 0.1% below the reference mean. With a Z-score of -0.01 (49.6th percentile), this represents normal volume ; middle temporal gyrus volume measures 17,568 mm³, 8.4% below the reference mean. With a Z-score of -0.73 (23.4th percentile), this represents normal volume . ",
  "text_data": "Age is 77.5 years. Gender is Female. Education: 20 years. MMSE: 30.0. MoCA: 29.0. Logical Memory: 19.0. APOEε4 alleles: 0.0. Biomarker levels: Florbetapir (AV45): 1.53 SUVR (profound elevated); Amyloid beta: 678.50 pg/mL (normal ); Total tau: 223.80 pg/mL (normal ); Phosphorylated tau: 20.77 pg/mL (normal ). ",
  "true_diagnosis": "Diagnosis: CN.",
  "gpt_diagnosis": "**Reasoning:** The data shows profound ventricular enlargement (142.8% above reference mean, Z-score 3.27), which is strongly indicative of significant brain atrophy, particularly in Alzheimer's disease. However, cognitive scores (MMSE 30, MoCA 29) are intact, and CSF biomarkers (Aβ, T-tau, P-tau) are normal despite elevated AV45 (amyloid PET), suggesting early amyloid deposition without clinical impairment.  \n\n**Diagnosis:** **Mild Cognitive Impairment (MCI)** (given structural atrophy but preserved cognition)  \n**Confidence:** **Medium** (conflicting evidence—severe atrophy but normal biomarkers and cognition)",
  "timestamp": "2025-07-26T02:19:30.432613"
}